Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Navin Venkatraman

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
BMJ Case Reports|August 8, 2014
Massive splenomegaly in rural Malawi: new wine, old wineskins and the importance of collaborationNavin Venkatraman, Charlotte White, Joanne Haensel
BMJ Case Reports|February 2, 2013
Invasive non-typhoidal salmonella infection with multifocal seeding in an immunocompetent host: an emerging disease in the developed worldRebecca Louise Hall, Rebecca Partridge, Navin Venkatraman, et al.
Vaccine|August 7, 2017
Vaccines against Ebola virusNavin Venkatraman, Daniel Silman, Pedro M Folegatti, et al.
Frontiers in Immunology|August 10, 2018
CXCR3<sup>+</sup> T Follicular Helper Cells Induced by Co-Administration of RTS,S/AS01B and Viral-Vectored Vaccines Are Associated With Reduced Immunogenicity and Efficacy Against MalariaGeorgina Bowyer, Amy Grobbelaar, Tommy Rampling, et al.
Vaccine|September 25, 2017
Safety and immunogenicity of heterologous prime-boost immunization with viral-vectored malaria vaccines adjuvanted with Matrix-M™Navin Venkatraman, Nicholas Anagnostou, Carly Bliss, et al.
Open Forum Infectious Diseases|March 23, 2016
Detection of Vaccine-Induced Antibodies to Ebola Virus in Oral FluidTeresa Lambe, Tommy Rampling, Dhan Samuel, et al.
The Journal of Experimental Medicine|May 16, 2020
Reduced Ebola vaccine responses in CMV+ young adults is associated with expansion of CD57+KLRG1+ T cellsGeorgina Bowyer, Hannah Sharpe, Navin Venkatraman, et al.
Scientific Reports|February 23, 2018
Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAPCarly M Bliss, Georgina Bowyer, Nicholas A Anagnostou, et al.
Elife|March 2, 2021
Mapping immune variation and <i>var</i> gene switching in naive hosts infected with <i>Plasmodium falciparum</i>Kathryn Milne, Alasdair Ivens, Adam J Reid, et al.
Science Translational Medicine|September 28, 2018
Prime and target immunization protects against liver-stage malaria in miceAnita Gola, Daniel Silman, Adam A Walters, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
BMJ Case Reports|August 8, 2014
Massive splenomegaly in rural Malawi: new wine, old wineskins and the importance of collaborationNavin Venkatraman, Charlotte White, Joanne Haensel
BMJ Case Reports|February 2, 2013
Invasive non-typhoidal salmonella infection with multifocal seeding in an immunocompetent host: an emerging disease in the developed worldRebecca Louise Hall, Rebecca Partridge, Navin Venkatraman, et al.
Vaccine|August 7, 2017
Vaccines against Ebola virusNavin Venkatraman, Daniel Silman, Pedro M Folegatti, et al.
Frontiers in Immunology|August 10, 2018
CXCR3<sup>+</sup> T Follicular Helper Cells Induced by Co-Administration of RTS,S/AS01B and Viral-Vectored Vaccines Are Associated With Reduced Immunogenicity and Efficacy Against MalariaGeorgina Bowyer, Amy Grobbelaar, Tommy Rampling, et al.
Vaccine|September 25, 2017
Safety and immunogenicity of heterologous prime-boost immunization with viral-vectored malaria vaccines adjuvanted with Matrix-M™Navin Venkatraman, Nicholas Anagnostou, Carly Bliss, et al.
Open Forum Infectious Diseases|March 23, 2016
Detection of Vaccine-Induced Antibodies to Ebola Virus in Oral FluidTeresa Lambe, Tommy Rampling, Dhan Samuel, et al.
The Journal of Experimental Medicine|May 16, 2020
Reduced Ebola vaccine responses in CMV+ young adults is associated with expansion of CD57+KLRG1+ T cellsGeorgina Bowyer, Hannah Sharpe, Navin Venkatraman, et al.
Scientific Reports|February 23, 2018
Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAPCarly M Bliss, Georgina Bowyer, Nicholas A Anagnostou, et al.
Elife|March 2, 2021
Mapping immune variation and <i>var</i> gene switching in naive hosts infected with <i>Plasmodium falciparum</i>Kathryn Milne, Alasdair Ivens, Adam J Reid, et al.
Science Translational Medicine|September 28, 2018
Prime and target immunization protects against liver-stage malaria in miceAnita Gola, Daniel Silman, Adam A Walters, et al.
Pageof 2